IL-2
Showing 1 - 25 of >10,000
Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal
Not yet recruiting
- Esophagus Cancer
- +4 more
- Intravenous injection of P-IL-2
- P-IL-2 plus Anti-PD-1 Monoclonal Antibody
- (no location specified)
Apr 24, 2023
Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)
Not yet recruiting
- Head and Neck Neoplasms
- TransCon TLR7/8 Agonist
- +2 more
- (no location specified)
Aug 4, 2023
Allergic Rhinoconjunctivitis to Birch Pollen, With a Positive Skin Prick Test to Birch Pollen Trial in Paris (ILT-101 ld-(IL2))
Completed
- Allergic Rhinoconjunctivitis to Birch Pollen
- With a Positive Skin Prick Test to Birch Pollen
- ILT-101 ld-(IL2)
-
Paris, FranceCIC Paris Est GH Pitié Salpétrière
Dec 13, 2022
Metastatic Melanoma Trial in Tampa (procedure, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Surgery
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)
Recruiting
- Metastatic Melanoma
- +9 more
- TBio-4101
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Metastatic Solid Tumor Trial ([18F]AlF-RESCA-IL2 PET scan)
Not yet recruiting
- Metastatic Solid Tumor
- [18F]AlF-RESCA-IL2 PET scan
- (no location specified)
Jul 20, 2022
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
HIV Infection Trial in Cleveland (Recombinant Interleukin-2)
Terminated
- HIV Infection
- Recombinant Interleukin-2
-
Cleveland, OhioAIDS Clinical Trials Unit
Sep 1, 2022
Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)
Completed
- Metastatic Renal Cell Carcinoma
- HD IL2
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jun 20, 2022
Metastatic Melanoma Trial in Tampa (drug, procedure, biological)
Active, not recruiting
- Metastatic Melanoma
- Ipilimumab
- +6 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022
NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Carcinoma Breast
- Vinorelbine
- +4 more
-
Suzhou, ChinaSecond Affiliated Hospital of Soochow University
Oct 29, 2022
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)
Not yet recruiting
- Triple Negative Breast Cancer
- Proleukin 1.3 MG Injection
- (no location specified)
Apr 6, 2023
Advanced Solid Tumor, Metastatic Cancer Trial in Miranda, Clayton, Heidelberg (AU-007, Aldesleukin)
Recruiting
- Advanced Solid Tumor
- Metastatic Cancer
-
Miranda, New South Wales, Australia
- +2 more
Jun 10, 2022
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Human umbilical cord mesenchymal stem cells
- Interleukin-2
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022
Multiple Sclerosis Trial in Rennes (Blood sampling, CSF sampling)
Recruiting
- Multiple Sclerosis
- Blood sampling
- CSF sampling
-
Rennes, FranceCHU Rennes
Apr 26, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,
Recruiting
- Advanced Solid Tumor
- +7 more
- TransCon IL-2 β/γ
- +4 more
-
Boston, Massachusetts
- +7 more
Nov 16, 2022
Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer Trial in Minneapolis (IP FT516, Enoblituzumab,
Completed
- Ovarian Cancer
- +2 more
- IP FT516
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota, Masonic Cancer Center
Apr 12, 2022
Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Histamine Dihydrochloride (HDC)
- Interleukin-2 (IL-2)
- (no location specified)
Mar 31, 2023
Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)
Recruiting
- Sjögren's Syndrome
- low-dose interleukin-2
- rapamycin
-
Beijing, Beijing, ChinaPeking university people's hospital
Dec 2, 2022
TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid
Not yet recruiting
- TIA
- +2 more
- Interleukin-2 [IL-2]
- Standard care - Carotid Endarterectomy
-
Cambridge, Cambridgeshire, United KingdomAddenbrookes Hospital
Aug 2, 2023